Encoded Therapeutics Funding: $240M Raised, Series D (2020)
Encoded Therapeutics is based in Foster City. It has raised $240M in total funding. Latest round: Series D. Backed by GV, Menlo Ventures, Anne Wojcicki.
Encoded Therapeutics funding overview
Encoded Therapeutics is based in Foster City. Encoded Therapeutics has raised $240M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in July 2020. The round record for Encoded Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include GV, Menlo Ventures, Anne Wojcicki, ARCH Venture Partners, Boxer Capital, Farallon Capital Management and 14 others. 20 distinct backers are named across the disclosed rounds.
Encoded Therapeutics at a glance
Total raised
$240M
Latest round
Series D
Latest round date
July 2020
Headquarters
Foster City
Notable investors
GV, Menlo Ventures, Anne Wojcicki, ARCH Venture Partners, Boxer Capital, Farallon Capital Management, HBM Genomics, Illumina Ventures
Frequently asked about Encoded Therapeutics funding
How much has Encoded Therapeutics raised?
Encoded Therapeutics has raised $240M in total disclosed funding across the rounds on record.
Who has invested in Encoded Therapeutics?
GV, Menlo Ventures, Anne Wojcicki, ARCH Venture Partners, Boxer Capital, Farallon Capital Management are named among the investors backing Encoded Therapeutics.
What was the latest Encoded Therapeutics funding round?
The most recent disclosed round is a Series D, announced in July 2020.
Where is Encoded Therapeutics based?
Encoded Therapeutics is based in Foster City.
When did Encoded Therapeutics last raise?
The last disclosed Encoded Therapeutics round closed in July 2020 at Series D.
Totals shown for Encoded Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Foster City and the investors behind them below.
